1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. LBX Pharmacy Chain Joint Stock Company
  6. News
  7. Summary
    603883   CNE1000023Q8

LBX PHARMACY CHAIN JOINT STOCK COMPANY

(603883)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-16
35.75 CNY   +0.14%
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021
CI
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/07LBX Pharmacy Chain Joint Stock Company singed an Asset Purchase Agreement to acquire a 71.9% stake in Hunan Huairen Great Health Industry Development Co., Ltd. from group of sellers for CNY 1.6 billion.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake in Jiangsu Baijiahui Suheda Pharmacy Chain Co., Ltd. from Cui Xufang and Xu Yuping.

11/15/2021 EDT

LBX Pharmacy Chain Joint Stock Company (SHSE:603883) entered into an agreement to acquire remaining 49% stake in Jiangsu Baijiahui Suheda Pharmacy Chain Co., Ltd. from Cui Xufang and Xu Yuping for CNY 68.9 million on July 16, 2021. After the transaction is approved and implemented, LBX Pharmacy need to complete the payment of the equity transfer price as agreed by the two parties after the agreement takes effect, after the completion of the settlement, and after the completion of the completion of the acquisition involving all tax and fee payment obligations. Upon completion, LBX Pharmacy will hold 100% stake in Jiangsu Baijiahui. In related transactions, LBX Pharmacy Chain Joint Stock Company agreed to acquire remaining 35% stake in Zhenjiang Huakang Pharmacy Chain Co., Ltd. and 49% stake in Taizhou Longtaiyuan Pharmaceutical Chain Co., Ltd. The transaction was funded by own funds of LBX Pharmacy. The transaction is subject to approval from shareholders of LBX Pharmacy and other possible approvals or approvals (if any) required by relevant laws and regulations. The transaction has been approved by the Board of LBX Pharmacy. As of August 20, 2021, shareholders of LBX Pharmacy Chain Joint Stock Company has approved the transaction. Wei Qinghua of DONGXING SECURITIES Company Limited (SHSE:601198) acted as financial advisor to LBX Pharmacy. Ding Shaobo, Xie Yongjun, Wu Juan, Wang Tianjiao, Zhao Chengjie of Hunan Qiyuan Law Firm acted as legal advisor; Li Dan, Chen Jianxiang, Shen Jing of PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) acted as accountant and Hu Shaoxian, Zhao Jiao, Zhou Ya of Pan-China Certified Public Accountants and Fang Wensen, Chen Zhi, Wang Weihua of Zhongshenhua Certified Public Accountants (Special general partnership) acted as accountant to LBX Pharmacy. Hu Jiahao, He Yuanquan and Xie Songsha of Zhongrui Shilian Assets Appraisal Group Co., Ltd. acted as the appraisers for LBX Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company (SHSE:603883) completed the acquisition of remaining 49% stake in Jiangsu Baijiahui Suheda Pharmacy Chain Co., Ltd. from Cui Xufang and Xu Yuping on November 15, 2021.


ę S&P Capital IQ 2021
All news about LBX PHARMACY CHAIN JOINT STOCK COMPANY
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended..
CI
04/28LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter E..
CI
03/07LBX Pharmacy Chain Joint Stock Company singed an Asset Purchase Agreement to acquire a ..
CI
03/06LBX Pharmacy Chain Joint Stock Company cancelled the acquisition of 51% stake in Hebei ..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake..
CI
2021LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months End..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of the remaining 35% s..
CI
2021LBX Pharmacy Chain Joint Stock Company completed the acquisition of remaining 49% stake..
CI
2021LBX Pharmacy Chain Joint Stock Company agreed to acquire 51% stake in Hebei Hua Tuo Pha..
CI
2021Lbx Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended..
CI
More news
Financials
Sales 2022 18 486 M 2 744 M 2 744 M
Net income 2022 798 M 118 M 118 M
Net Debt 2022 1 649 M 245 M 245 M
P/E ratio 2022 20,4x
Yield 2022 1,10%
Capitalization 15 950 M 2 367 M 2 367 M
EV / Sales 2022 0,95x
EV / Sales 2023 0,86x
Nbr of Employees -
Free-Float 45,5%
Chart LBX PHARMACY CHAIN JOINT STOCK COMPANY
Duration : Period :
LBX Pharmacy Chain Joint Stock Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LBX PHARMACY CHAIN JOINT STOCK COMPANY
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 35,75 CNY
Average target price 59,92 CNY
Spread / Average Target 67,6%
EPS Revisions
Managers and Directors
Li Wang President
Jing Yang Zhu Chief Financial Officer
Zi Long Xie Chairman
Cheng Xiang Wang Chairman-Supervisory Board
Zhe Min Dan Independent Director
Sector and Competitors